{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:46:00Z","timestamp":1783298760236,"version":"3.54.6"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008130","name":"Pusan National University Hospital","doi-asserted-by":"publisher","award":["2019B011"],"award-info":[{"award-number":["2019B011"]}],"id":[{"id":"10.13039\/501100008130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012403","name":"Texas Biomedical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.tjog.2022.07.010","type":"journal-article","created":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T14:24:13Z","timestamp":1675002253000},"page":"66-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Validation of multi-gene panel next-generation sequencing for the detection of BRCA mutation in formalin-fixed, paraffin-embedded epithelial ovarian cancer tissues"],"prefix":"10.1016","volume":"62","author":[{"given":"Eun Taeg","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Eun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Joon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Soo","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjog.2022.07.010_bib1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.humpath.2005.06.006","article-title":"Hereditary ovarian cancer","volume":"36","author":"Prat","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.tjog.2022.07.010_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/341723","article-title":"Hereditary ovarian cancer: not only BRCA 1 and 2 genes","volume":"2015","author":"Toss","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.tjog.2022.07.010_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.tjog.2022.07.010_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cncr.29041","article-title":"Cancers associated with BRCA 1 and BRCA 2 mutations other than breast and ovarian","volume":"121","author":"Mersch","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.tjog.2022.07.010_bib5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ejso.2006.03.032","article-title":"High incidence of BRCA1\u20132 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma","volume":"32","author":"Biron-Shental","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.tjog.2022.07.010_bib6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.tjog.2022.07.010_bib7","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.tjog.2022.07.010_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/1758834017714993","article-title":"BRCA mutation in ovarian cancer: testing, implications and treatment considerations","volume":"9","author":"Neff","year":"2017","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.tjog.2022.07.010_bib9","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.18632\/oncotarget.6834","article-title":"BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing","volume":"7","author":"Mafficini","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tjog.2022.07.010_bib10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","article-title":"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas","volume":"20","author":"Pennington","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.tjog.2022.07.010_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2017.08.022","article-title":"Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: integrated analysis of data from Study 10 and ARIEL2","volume":"147","author":"Oza","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2022.07.010_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.tjog.2022.07.010_bib13","doi-asserted-by":"crossref","first-page":"61845","DOI":"10.18632\/oncotarget.11259","article-title":"Simultaneous detection of BRCA mutations and large genomic rearrangements in germline DNA and FFPE tumor samples","volume":"7","author":"Enyedi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tjog.2022.07.010_bib14","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4143\/crt.2018.312","article-title":"Clinical and genetic characteristics of BRCA1\/2 mutation in Korean ovarian cancer patients: a multicenter study and literature Review","volume":"51","author":"Kwon","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.tjog.2022.07.010_bib15","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12885-019-5584-6","article-title":"Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples","volume":"19","author":"Zakrzewski","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tjog.2022.07.010_bib16","doi-asserted-by":"crossref","first-page":"43653","DOI":"10.18632\/oncotarget.17613","article-title":"Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting","volume":"8","author":"Dougherty","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tjog.2022.07.010_bib17","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","article-title":"Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer","volume":"375","author":"Mirza","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.tjog.2022.07.010_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jmoldx.2016.09.006","article-title":"Deamination effects in formalin-fixed, paraffin-embedded tissue samples in the era of precision medicine","volume":"19","author":"Kim","year":"2017","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.tjog.2022.07.010_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152595","article-title":"BRCA1\/2 somatic mutation detection in formalin-fixed paraffin embedded tissue by next-generation sequencing in Korean ovarian cancer patients","volume":"215","author":"Lee","year":"2019","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.tjog.2022.07.010_bib20","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6661","article-title":"Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast\/ovarian cancer","volume":"7","author":"Nicolussi","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.tjog.2022.07.010_bib21","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1200\/JCO.2009.27.2997","article-title":"Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer","volume":"28","author":"Hennessy","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.tjog.2022.07.010_bib22","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","article-title":"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas","volume":"20","author":"Pennington","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.tjog.2022.07.010_bib23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020","volume":"18","author":"Daly","year":"2020","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.tjog.2022.07.010_bib24","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/jnci\/djx265","article-title":"Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women","volume":"110","author":"Manchanda","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.tjog.2022.07.010_bib25","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.21037\/atm-20-1582","article-title":"Ovarian cancer risk assessment in the era of next-generation sequencing","volume":"8","author":"Bonadio","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.tjog.2022.07.010_bib26","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/ejhg.2016.94","article-title":"New challenges for BRCA testing: a view from the diagnostic laboratory","volume":"24","author":"Wallace","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.tjog.2022.07.010_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/AOG.0b013e31825f3576","article-title":"Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy","volume":"120","author":"Schrader","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tjog.2022.07.010_bib28","doi-asserted-by":"crossref","first-page":"896","DOI":"10.6004\/jnccn.2019.0039","article-title":"NCCN guidelines insights: ovarian cancer, version 1.2019","volume":"17","author":"Armstrong","year":"2019","journal-title":"J\u00a0Natl Compr Cancer Netw"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455922003448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455922003448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:21:05Z","timestamp":1760898065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455922003448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1028455922003448"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2022.07.010","relation":{},"ISSN":["1028-4559"],"issn-type":[{"value":"1028-4559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of multi-gene panel next-generation sequencing for the detection of BRCA mutation in formalin-fixed, paraffin-embedded epithelial ovarian cancer tissues","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2022.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}